Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 17 studies | 36% ± 8% | |
brain | 17 studies | 32% ± 16% | |
lung | 16 studies | 25% ± 8% | |
intestine | 5 studies | 23% ± 11% | |
kidney | 4 studies | 25% ± 8% | |
eye | 4 studies | 28% ± 10% | |
lymph node | 4 studies | 26% ± 5% | |
liver | 4 studies | 29% ± 3% | |
adipose | 4 studies | 27% ± 3% | |
pancreas | 3 studies | 43% ± 7% | |
bone marrow | 3 studies | 24% ± 8% | |
heart | 3 studies | 19% ± 2% | |
uterus | 3 studies | 29% ± 12% | |
breast | 3 studies | 19% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 5302.36 | 459 / 459 | 100% | 43.37 | 1118 / 1118 |
prostate | 100% | 5375.78 | 245 / 245 | 100% | 37.26 | 502 / 502 |
uterus | 100% | 6152.55 | 170 / 170 | 100% | 41.10 | 459 / 459 |
brain | 100% | 5999.53 | 2641 / 2642 | 100% | 67.15 | 705 / 705 |
thymus | 100% | 4202.92 | 653 / 653 | 100% | 44.56 | 604 / 605 |
skin | 100% | 4570.26 | 1808 / 1809 | 100% | 69.74 | 471 / 472 |
lung | 100% | 5067.06 | 577 / 578 | 100% | 33.66 | 1153 / 1155 |
ovary | 100% | 7068.99 | 180 / 180 | 100% | 31.73 | 428 / 430 |
esophagus | 100% | 5985.63 | 1445 / 1445 | 99% | 20.47 | 182 / 183 |
kidney | 100% | 4605.97 | 89 / 89 | 99% | 41.47 | 896 / 901 |
intestine | 100% | 6068.42 | 966 / 966 | 99% | 25.90 | 524 / 527 |
bladder | 100% | 6280.33 | 21 / 21 | 99% | 33.97 | 501 / 504 |
stomach | 100% | 3275.74 | 359 / 359 | 99% | 22.71 | 284 / 286 |
adrenal gland | 100% | 3239.22 | 258 / 258 | 97% | 28.30 | 224 / 230 |
pancreas | 93% | 1779.75 | 305 / 328 | 99% | 37.46 | 177 / 178 |
liver | 63% | 844.56 | 142 / 226 | 63% | 10.68 | 255 / 406 |
adipose | 100% | 5098.91 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 7693.68 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 62.93 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 32.47 | 29 / 29 |
spleen | 100% | 5658.10 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 40.75 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 16.18 | 1 / 1 |
peripheral blood | 98% | 4252.10 | 911 / 929 | 0% | 0 | 0 / 0 |
heart | 97% | 2981.55 | 839 / 861 | 0% | 0 | 0 / 0 |
muscle | 67% | 1024.92 | 539 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0048588 | Biological process | developmental cell growth |
GO_0007165 | Biological process | signal transduction |
GO_0006338 | Biological process | chromatin remodeling |
GO_0032088 | Biological process | negative regulation of NF-kappaB transcription factor activity |
GO_0006479 | Biological process | protein methylation |
GO_0019919 | Biological process | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0060765 | Biological process | regulation of androgen receptor signaling pathway |
GO_2000134 | Biological process | negative regulation of G1/S transition of mitotic cell cycle |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0005730 | Cellular component | nucleolus |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0046966 | Molecular function | nuclear thyroid hormone receptor binding |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_0030331 | Molecular function | nuclear estrogen receptor binding |
GO_0042054 | Molecular function | histone methyltransferase activity |
GO_0042974 | Molecular function | nuclear retinoic acid receptor binding |
GO_0042975 | Molecular function | peroxisome proliferator activated receptor binding |
GO_0050681 | Molecular function | nuclear androgen receptor binding |
GO_0016274 | Molecular function | protein-arginine N-methyltransferase activity |
GO_0140938 | Molecular function | histone H3 methyltransferase activity |
GO_0035242 | Molecular function | protein-arginine omega-N asymmetric methyltransferase activity |
GO_0003713 | Molecular function | transcription coactivator activity |
GO_0033142 | Molecular function | nuclear progesterone receptor binding |
GO_0005515 | Molecular function | protein binding |
GO_0140592 | Molecular function | histone H3R8 methyltransferase activity |
Gene name | PRMT2 |
Protein name | Protein arginine methyltransferase 2 isoform 2 Protein arginine methyltransferase 2 isoform 3 PRMT2 protein Protein arginine N-methyltransferase 2 (EC 2.1.1.319) (Histone-arginine N-methyltransferase PRMT2) Protein arginine methyltransferase 2 Protein arginine methyltransferase 2 isoform 1 |
Synonyms | HRMT1L1 HMT1 |
Description | FUNCTION: Arginine methyltransferase that methylates the guanidino nitrogens of arginyl residues in proteins such as STAT3, FBL, histone H4. Acts as a coactivator (with NCOA2) of the androgen receptor (AR)-mediated transactivation. Acts as a coactivator (with estrogen) of estrogen receptor (ER)-mediated transactivation. Enhances PGR, PPARG, RARA-mediated transactivation. May inhibit NF-kappa-B transcription and promote apoptosis. Represses E2F1 transcriptional activity (in a RB1-dependent manner). May be involved in growth regulation. . |
Accessions | A0A0S2Z3W8 ENST00000355680.8 [P55345-1] ENST00000458387.6 [P55345-5] H7C2H9 A0A0S2Z3Q3 ENST00000334494.8 [P55345-2] ENST00000451211.6 [P55345-4] P55345 ENST00000397637.5 [P55345-1] ENST00000397628.5 ENST00000455177.3 A0A0S2Z3N3 ENST00000291705.11 [P55345-6] ENST00000397638.6 [P55345-1] A8MXR3 Q49AF9 ENST00000440086.5 [P55345-3] |